{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:51:41Z","timestamp":1773229901168,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cyto.2025.157039","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:37:42Z","timestamp":1760139462000},"page":"157039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anakinra ameliorates insulin resistance and inflammation in a murine model of gestational diabetes through downregulation of Th17 responses Anakinra for the treatment of GDM in mice"],"prefix":"10.1016","volume":"196","author":[{"given":"Lingyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fudan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaik Althaf","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2025.157039_bb0005","first-page":"91","article-title":"Pathophysiology of gestational diabetes mellitus: The past, the present and the future","volume":"6","author":"Al-Noaemi","year":"2011","journal-title":"Gestat. Diab."},{"issue":"12","key":"10.1016\/j.cyto.2025.157039_bb0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4239\/wjd.v8.i12.489","article-title":"Gestational diabetes from A to Z","volume":"8","author":"Dirar","year":"2017","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.cyto.2025.157039_bb0015","first-page":"1","article-title":"Impact of systemic inflammation on the progression of gestational diabetes mellitus","volume":"16","author":"Lekva","year":"2016","journal-title":"Curr. Diab. Reports"},{"issue":"1","key":"10.1016\/j.cyto.2025.157039_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"De Luca","year":"2008","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.cyto.2025.157039_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.immuni.2018.07.017","article-title":"Interferons and proinflammatory cytokines in pregnancy and fetal development","volume":"49","author":"Yockey","year":"2018","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/j.cyto.2025.157039_bb0030","doi-asserted-by":"crossref","first-page":"11409","DOI":"10.3390\/ijms252111409","article-title":"Gestational diabetes mellitus-induced inflammation in the placenta via IL-1\u03b2 and toll-like receptor pathways","volume":"25","author":"Zgutka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2025.157039_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.531543","article-title":"Maternal-fetal inflammation in the placenta and the developmental origins of health and disease","volume":"11","author":"Goldstein","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2025.157039_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mam.2018.11.002","article-title":"Diabesity-associated oxidative and inflammatory stress signalling in the early human placenta","volume":"66","author":"Hoch","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2025.157039_bb0045","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/aji.12454","article-title":"Oxidative stress: placenta function and dysfunction","volume":"76","author":"Wu","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2025.157039_bb0050","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.autrev.2014.08.019","article-title":"Th17 cells in inflammation and autoimmunity","volume":"13","author":"Singh","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2025.157039_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/2058739218793550","article-title":"Changes in intestinal flora, TNF-\u03b1, L-17, and IL-6 levels in patients with gestational diabetes mellitus","volume":"16","author":"Yu","year":"2018","journal-title":"Eur. J. Inflamm."},{"issue":"1","key":"10.1016\/j.cyto.2025.157039_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21873\/invivo.11435","article-title":"Gestational diabetes and T-cell (Th1\/Th2\/Th17\/Treg) immune profile","volume":"33","author":"Sifnaios","year":"2019","journal-title":"In Vivo"},{"key":"10.1016\/j.cyto.2025.157039_bb0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13679-014-0124-9","article-title":"Low-grade inflammation, obesity, and diabetes","volume":"3","author":"Pereira","year":"2014","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.cyto.2025.157039_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11010-019-03561-4","article-title":"Role and mechanism of the Th17\/Treg cell balance in the development and progression of insulin resistance","volume":"459","author":"Tao","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.cyto.2025.157039_bb0075","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/cmi.2014.54","article-title":"TH17 cells in human recurrent pregnancy loss and pre-eclampsia","volume":"11","author":"Fu","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"48","key":"10.1016\/j.cyto.2025.157039_bb0080","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e338","article-title":"Increased pro-inflammatory T cells, senescent T cells, and immune-check point molecules in the placentas of patients with gestational diabetes mellitus","volume":"37","author":"Kang","year":"2022","journal-title":"J. Korean Med. Sci."},{"issue":"8","key":"10.1016\/j.cyto.2025.157039_bb0085","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.3390\/ijms22084261","article-title":"Gestational diabetes mellitus and maternal immune dysregulation: what we know so far","volume":"22","author":"McElwain","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2025.157039_bb0090","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3389\/fimmu.2019.01587","article-title":"Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157039_bb0095","doi-asserted-by":"crossref","DOI":"10.4110\/in.2022.22.e13","article-title":"The role of T cells in obesity-associated inflammation and metabolic disease","volume":"22","author":"Park","year":"2022","journal-title":"Immune Netw."},{"issue":"11","key":"10.1016\/j.cyto.2025.157039_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13952","article-title":"Protective effect of sinomenine against inflammation and oxidative stress in gestational diabetes mellitus in female rats via TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"45","author":"Li","year":"2021","journal-title":"J. Food Biochem."},{"issue":"01","key":"10.1016\/j.cyto.2025.157039_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/a-1250-8221","article-title":"Blockade of CCL2\/CCR2 signaling pathway exerts anti-inflammatory effects and attenuates gestational diabetes mellitus in a genetic mice model","volume":"53","author":"Qi","year":"2021","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cyto.2025.157039_bb0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra therapy for non-cancer inflammatory diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.cyto.2025.157039_bb0115","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/nu14163422","article-title":"IL-1 receptor antagonist (IL-1Ra) levels and management of metabolic disorders","volume":"14","author":"Luotola","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.cyto.2025.157039_bb0120","first-page":"1","article-title":"Immunotherapies for prevention and treatment of type 1 diabetes","author":"Jeun","year":"2025","journal-title":"Immunotherapy"},{"key":"10.1016\/j.cyto.2025.157039_bb0125","first-page":"1","article-title":"Targeting the NLRP3 inflammasome\u2013IL-1\u03b2 pathway in type 2 diabetes and obesity","author":"Meier","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.cyto.2025.157039_bb0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-014-2601-7","article-title":"Anakinra treatment in patients with gout and type 2 diabetes","volume":"34","author":"Vitale","year":"2015","journal-title":"Clin. Rheumatol."},{"issue":"Supplement_2","key":"10.1016\/j.cyto.2025.157039_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.1199","article-title":"Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies","volume":"44","author":"Moroni","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2025.157039_bb0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.55563\/clinexprheumatol\/phsqg7","article-title":"Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from","volume":"39","author":"Ruscitti","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2025.157039_bb0145","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1038\/s41598-020-59701-0","article-title":"Inhibition of IL-1beta improves glycaemia in a mouse model for gestational diabetes","volume":"10","author":"Schulze","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2025.157039_bb0150","article-title":"Association between gestational diabetes and proinflammatory Cytokine (IL-1\u03b2)","volume":"15","author":"Yousif","year":"2021","journal-title":"Indian J. Foren. Med. Toxicol."},{"issue":"2","key":"10.1016\/j.cyto.2025.157039_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2015.06.003","article-title":"One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus","volume":"160","author":"van Asseldonk","year":"2015","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2025.157039_bb0160","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/key093","article-title":"Five successful pregnancies with antenatal anakinra exposure","volume":"57","author":"Smith","year":"2018","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.cyto.2025.157039_bb0165","article-title":"Safety and efficacy of canakinumab for the prevention and control of type 2 diabetes mellitus and its complications: a systematic review","volume":"16","author":"Lanka","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.cyto.2025.157039_bb0170","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399411002109","article-title":"PI3K\/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis","volume":"14","author":"Schultze","year":"2012","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.cyto.2025.157039_bb0175","first-page":"1","article-title":"Current review on IRS-1, JNK, NF-\u039aB & m-TOR pathways in insulin resistance","volume":"11","author":"Saraswat","year":"2020","journal-title":"Pharmacophores"},{"issue":"8","key":"10.1016\/j.cyto.2025.157039_bb0180","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1096\/fj.09-151340","article-title":"JNK1 and IKK\u03b2: molecular links between obesity and metabolic dysfunction","volume":"24","author":"Solinas","year":"2010","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.cyto.2025.157039_bb0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/bcpt.13524","article-title":"Dendrobine attenuates gestational diabetes mellitus in mice by inhibiting Th17 cells","volume":"128","author":"Feng","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.cyto.2025.157039_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157185","article-title":"Positive correlation between enhanced expression of TLR4\/MyD88\/NF-\u03baB with insulin resistance in placentae of gestational diabetes mellitus","volume":"11","author":"Feng","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2025.157039_bb0195","article-title":"An overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions","volume":"20","author":"Barrow","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.cyto.2025.157039_bb0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/10641955.2011.642436","article-title":"Activation of NF-\u03baB in placentas of women with preeclampsia","volume":"31","author":"Vaughan","year":"2012","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.cyto.2025.157039_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102213","article-title":"Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus","volume":"163","author":"Duan","year":"2020","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"1","key":"10.1016\/j.cyto.2025.157039_bb0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40268-022-00382-7","article-title":"NLRP3 inhibitor tranilast attenuates gestational diabetes mellitus in a genetic mouse model","volume":"22","author":"Cao","year":"2022","journal-title":"Drugs R&D"},{"key":"10.1016\/j.cyto.2025.157039_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-019-0522-7","article-title":"Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice","volume":"17","author":"Zhang","year":"2019","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"12","key":"10.1016\/j.cyto.2025.157039_bb0220","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1089\/ars.2010.3765","article-title":"The role of oxidative stress in the pathophysiology of gestational diabetes mellitus","volume":"15","author":"Lappas","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.cyto.2025.157039_bb0225","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s00210-020-01861-x","article-title":"Astaxanthin alleviates gestational diabetes mellitus in mice through suppression of oxidative stress","volume":"393","author":"Chen","year":"2020","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.cyto.2025.157039_bb0230","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s12272-019-01197-y","article-title":"Tetramethylpyrazine attenuates placental oxidative stress, inflammatory responses and endoplasmic reticulum stress in a mouse model of gestational diabetes mellitus","volume":"42","author":"Jiao","year":"2019","journal-title":"Arch. Pharm. Res."},{"issue":"9","key":"10.1016\/j.cyto.2025.157039_bb0235","doi-asserted-by":"crossref","first-page":"15310","DOI":"10.1002\/jcb.28798","article-title":"Tertiary butylhydroquinone alleviates gestational diabetes mellitus in C57BL\/KsJ-Lep db\/+ mice by suppression of oxidative stress","volume":"120","author":"Song","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cyto.2025.157039_bb0240","series-title":"Evolving Mechanistic Insights into Galectin Functions, Galectins: Methods and Protocols","first-page":"1","author":"Arthur","year":"2015"},{"key":"10.1016\/j.cyto.2025.157039_bb0245","doi-asserted-by":"crossref","first-page":"9618092","DOI":"10.1155\/2016\/9618092","article-title":"Role of galectin-3 in obesity and impaired glucose homeostasis","volume":"2016","author":"Menini","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.cyto.2025.157039_bb0250","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/glycob\/cwab040","article-title":"Galectin-1 impacts on glucose homeostasis by modulating pancreatic insulin release","volume":"31","author":"Sundblad","year":"2021","journal-title":"Glycobiology"},{"issue":"2","key":"10.1016\/j.cyto.2025.157039_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057915","article-title":"Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice","volume":"8","author":"Pang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cyto.2025.157039_bb0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","article-title":"Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction","volume":"28","author":"Papaspyridonos","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:45:01Z","timestamp":1773153901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625001863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S1043466625001863"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157039","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anakinra ameliorates insulin resistance and inflammation in a murine model of gestational diabetes through downregulation of Th17 responses Anakinra for the treatment of GDM in mice","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.157039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157039"}}